Global Liver Disease Treatment Market Insights and Forecast Analysis 2021

According to the report “Liver Disease Treatment Market", published by Market Data Forecast, the global market is projected to reach USD 17.25 billion with a CAGR of 11.72% from USD 9.25 billion in 2016.

View Report at http://www.marketdataforecast.com/market-reports/global-liver-disease-treatment-market-1733/

Liver is a vital organ of the body performing umpteen complex functions such as fighting infections, removing toxins, bile secretion, and it produces clotting factors, proteins, and cholesterol, among others. Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases (hepatitis, non-alcoholic fatty liver disease, liver cancer, liver tumour, and liver cirrhosis, among others). The initial symptoms of liver damage include nausea, fatigue, diarrhoea, jaundice, swollen abdomen, and mental disorientation among other. Acute liver damage can be treated through proper medication, if detected early, otherwise liver transplant is required. Liver damage can be prevented by adopting healthy lifestyle and practicing proper hygiene.

Get free sample report at http://www.marketdataforecast.com/market-reports/global-liver-disease-treatment-market-1733/request-sample

The growth of Liver Disease Treatment market is majorly driven by factors such as boost in Research & Development investment, unorganized lifestyle, rising public awareness, growth in geriatric population, and unmet needs for the treatment of liver cancer. Additionally, spur in demand for alcohol has increased the risk of liver cirrhosis. According to World Health Organization, alcohol consumption is anticipated to cause 20% to 50% of cirrhosis of the liver. Also, growing obese population has also increased the risk of non-alcoholic fatty liver disease which is caused by build-up of fat in the liver. The obese population has doubled since 1980. In 2014, approximately 13% of the world’s population, that is, more than 600 million adults were obese as per World Health Organization

The global Liver Disease Treatment Market is segmented on the basis of Treatment Modality and Disease Type

Based on Treatment Modality
• Antiviral
• Vaccines
• Chemotherapy
• Immunosuppressive Agents
• Corticosteroids
• Others

Based on Disease Type
• Hepatitis
• Non-Alcoholic Fatty Liver Disease
• Alcohol-Induced
• Liver Cancer
• Others

Geographical Segmentation:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The major companies dominating the global Liver Disease Treatment Market are Gilead Science Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany), and AstraZeneca (United Kingdom).

About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact:
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 9985550206
Mail: abhishek@marketdataforecast.com
Jubilee Gardens,
Hyderabad, India.

This release was published on openPR.